
    
      Generic emtricitabine(FTC) has been approved for treatment of naive chronic hepatitis B(CHB)
      patients in China. Yet data are limited for this agent in children paitients. The
      investigators design this trial to test the effect of FTC in Chinese children CHB which
      including naive HBeAg positive and Negative CHB patients.
    
  